Literature DB >> 31486728

Reducing Disparities in the Quality of Palliative Care for Older African Americans through Improved Advance Care Planning: Study Design and Protocol.

Deborah B Ejem1, Nadine Barrett2, Ramona L Rhodes3, Maren Olsen4,5, Marie Bakitas6,7, Raegan Durant1, Ronit Elk7, Karen Steinhauser2, Tammie Quest8, Rowena J Dolor2, Kimberly Johnson9.   

Abstract

Advance care planning (ACP) improves end-of-life care for patients and their caregivers. However, only one-third of adults have participated in ACP and rates are substantially lower among African Americans than among whites. Importantly, ACP improves many domains of care where there are racial disparities in outcomes, including receipt of goal-concordant care, hospice use, and provider communication. Yet, few studies have examined the effectiveness of ACP interventions among African Americans. The objectives of reducing disparities in the quality of palliative care for older African Americans through improved advance care planning (EQUAL ACP) are as follows: to compare the effectiveness of two interventions in (1) increasing ACP among African Americans and whites and (2) reducing racial disparities in both ACP and end-of-life care; and to examine whether racial concordance of the interventionist and patient is associated with ACP. EQUAL ACP is a longitudinal, multisite, cluster randomized trial and a qualitative study describing the ACP experience of participants. The study will include 800 adults ≥65 years of age (half African American and half white) from 10 primary care clinics in the South. Eligible patients have a serious illness (advanced cancer, heart failure, lung disease, etc.), disability in activities of daily living, or recent hospitalization. Patients are followed for one year and participate in either a patient-guided, self-management ACP approach, including a Five Wishes form or structured ACP with Respecting Choices First Steps. The primary outcome is formal or informal ACP-completion of advance directives, documented discussions with clinicians, and other written or verbal communication with surrogate decision makers about care preferences. Secondary outcomes assessed through after-death interviews with surrogates of patients who die during the study include receipt of goal-concordant care, health services use in the last year of life, and satisfaction with care. EQUAL ACP is the first large study to assess which strategies are most effective at both increasing rates of ACP and promoting equitable palliative care outcomes for seriously ill African Americans.

Entities:  

Keywords:  African Americans; advance care planning; end of life; five wishes; racial disparities; respecting choices

Mesh:

Year:  2019        PMID: 31486728     DOI: 10.1089/jpm.2019.0146

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  10 in total

1.  Telemedicine Utilization in the Ambulatory Palliative Care Setting: Are There Disparities?

Authors:  Julia L Frydman; Asem Berkalieva; Bian Liu; Bethann M Scarborough; Madhu Mazumdar; Cardinale B Smith
Journal:  J Pain Symptom Manage       Date:  2021-10-10       Impact factor: 3.612

2.  Access to Palliative Care Consultation for Hospitalized Adults with COVID-19 in an Urban Health System: Were There Disparities at the Peak of the Pandemic?

Authors:  Julia L Frydman; Melissa Aldridge; Jaison Moreno; Joshua Singer; Li Zeng; Emily Chai; R Sean Morrison; Laura P Gelfman
Journal:  J Palliat Med       Date:  2021-10-08       Impact factor: 2.947

3.  Place of Death for Individuals With Chronic Lung Disease: Trends and Associated Factors From 2003 to 2017 in the United States.

Authors:  Sarah H Cross; E Wesley Ely; Dio Kavalieratos; James A Tulsky; Haider J Warraich
Journal:  Chest       Date:  2020-03-27       Impact factor: 9.410

4.  African American Recruitment in Early Heart Failure Palliative Care Trials: Outcomes and Comparison With the ENABLE CHF-PC Randomized Trial.

Authors:  Macy L Stockdill; J Nicholas Dionne-Odom; Rachel Wells; Deborah Ejem; Andres Azuero; Konda Keebler; Elizabeth Sockwell; Sheri Tims; Kathryn L Burgio; Sally Engler; Raegan Durant; Salpy V Pamboukian; Jose Tallaj; Keith M Swetz; Elizabeth Kvale; Rodney Tucker; Marie Bakitas
Journal:  J Palliat Care       Date:  2020-12-01       Impact factor: 1.980

5.  Advance care planning for adults with heart failure.

Authors:  Yuri Nishikawa; Natsuko Hiroyama; Hiroki Fukahori; Erika Ota; Atsushi Mizuno; Mitsunori Miyashita; Daisuke Yoneoka; Joey Sw Kwong
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

6.  The Effect of Health Literacy on a Brief Intervention to Improve Advance Directive Completion: A Randomized Controlled Study.

Authors:  Paige C Barker; Neal P Holland; Oliver Shore; Robert L Cook; Yang Zhang; Carrie D Warring; Melanie G Hagen
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

Review 7.  Disparities in Palliative and Hospice Care and Completion of Advance Care Planning and Directives Among Non-Hispanic Blacks: A Scoping Review of Recent Literature.

Authors:  Mohsen Bazargan; Shahrzad Bazargan-Hejazi
Journal:  Am J Hosp Palliat Care       Date:  2020-12-08       Impact factor: 2.500

8.  Repeat hospital transfers among long stay nursing home residents: a mixed methods analysis of age, race, code status and clinical complexity.

Authors:  Amy Vogelsmeier; Lori Popejoy; Elizabeth Fritz; Kelli Canada; Bin Ge; Lea Brandt; Marilyn Rantz
Journal:  BMC Health Serv Res       Date:  2022-05-10       Impact factor: 2.908

Review 9.  Deconstructing the Complexities of Advance Care Planning Outcomes: What Do We Know and Where Do We Go? A Scoping Review.

Authors:  Ryan D McMahan; Ismael Tellez; Rebecca L Sudore
Journal:  J Am Geriatr Soc       Date:  2020-09-07       Impact factor: 5.562

10.  Changes in the place of death for older adults with cancer: Reason to celebrate or a risk for unintended disparities?

Authors:  Ramy Sedhom; Pei-Lun Kuo; Arjun Gupta; Thomas J Smith; Fumiko Chino; Michael A Carducci; Karen Bandeen-Roche
Journal:  J Geriatr Oncol       Date:  2020-10-26       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.